University of York Scientists Solve 40-Year Medical Mystery to Uncover Sleeping Sickness "Molecular Shredder"

York researchers discover the ESB2 protein, a "molecular blade" that helps the Sleeping Sickness parasite stay invisible, opening doors for new treatments.

By: AXL Media

Published: Mar 30, 2026, 10:33 AM EDT

Source: Information for this report was sourced from the University of York

The Invisible Cloak of the African Trypanosome

To survive within the human bloodstream, the African trypanosome—the parasite responsible for Sleeping Sickness—employs a sophisticated defense mechanism known as the variant surface glycoprotein (VSG) cloak. This protein shield allows the parasite to remain invisible to the host’s immune system. While scientists have long understood the existence of this cloak, the precise method by which the parasite regulates its production has remained a "cold case" for four decades. A new study published in Nature Microbiology has finally identified the ESB2 protein as the critical component that fine-tunes this protective layer, marking a significant milestone for the University of York’s life sciences division.

A Molecular Blade Inside the Protein Factory

The discovery of the ESB2 protein reveals a "molecular shredder" located directly within the parasite's protein production hub, known as the Expression Site Body. Unlike most organisms that regulate traits by choosing what to "print" from their genetic manual, the trypanosome controls its environment through surgical destruction. As the parasite’s genetic instructions are being transcribed, ESB2 acts as a molecular blade, instantly shredding "helper" genetic sections while leaving the instructions for the protective cloak intact. This real-time redaction ensures the parasite produces a massive volume of cloak proteins but only minute amounts of other survival proteins.

Neurological Devastation of Sleeping Sickness

Transmitted through the bite of the tsetse fly, Sleeping Sickness (Human African Trypanosomiasis) remains a devastating threat to communities in sub-Saharan Africa. If the infection is left untreated, the parasites eventually breach the blood-brain barrier and invade the central nervous system. This transition leads to severe neurological degradation, characterized by profound confusion, daytime sleepiness paired with nighttime insomnia, and eventually, coma and death. By identifying the ESB2 protein, researchers have exposed a fundamental vulnerability in the parasite's life cycle that could be exploited to prevent this neurological collapse.